Authors:
The only book of its kind that describes how the industry develops and selects dermal drugs, complete with its challenges and opportunities
Discusses how the science can be used for increased success by clinicians when working with their patients and the abundance of new targets for dermatology
Covers the scientific gaps that exist in terms of dermal pharmacokinetics and the resulting uncertainty by clinicians when choosing a drug candidate
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (12 chapters)
-
Front Matter
-
Back Matter
About this book
The authors show how the pharmaceutical industry faces the development of dermal drugs and provide the only book of its kind that describes how the industry develops and selects dermal drugs, complete with the challenges and opportunities of the field. Delivery of drugs through the skin has been an attractive and challenging area for research, and advances in modern technologies have resulted in a larger number of drugs being delivered transdermally, including conventional hydrophobic small molecule drugs, hydrophilic drugs and macromolecules. Offering the perspective from the industrial side of selection and development of drugs, the primary audience is geared towards the pharmaceutical industry but can also offer valuable information to clinicians, compounding pharmacists, and similarly pharmacy students. Dermal Drug Selection and Development covers the
scientific gaps that exist in terms of dermal pharmacokinetics and the resulting uncertainty by clinicians when choosing a drug candidate.Reviews
Authors and Affiliations
-
Oncodesign, Centre de Recherches François Hyafil, Villebon sur Yvette, France
Lionel Trottet
-
Dermatology Department, Medical School, University of California, San Francisco, USA
Howard Maibach, MD
About the authors
Howard Maibach, MD is an expert in contact and occupational dermatitis and sees patients at the Environmental Dermatosis Clinic, which is part of the Dermatology Clinic at University of California, San Francisco (UCSF). His specialty is dermatotoxicology, or skin exposure toxicity; allergies and skin disorders; and dermatopharmacology or the study of medications for skin disorders. Dr. Maibach has been on the editorial board of more than 30 scientific journals and is a member of 19 professional societies including the American Academy of Dermatology, San Francisco Dermatolo
gical Society and the Internal Commission on Occupation Health. He is a professor in the Department of Dermatology at UCSF.
Bibliographic Information
Book Title: Dermal Drug Selection and Development
Book Subtitle: An Industrial Perspective
Authors: Lionel Trottet, Howard Maibach, MD
DOI: https://doi.org/10.1007/978-3-319-59504-7
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing AG 2017
Hardcover ISBN: 978-3-319-59503-0Published: 16 August 2017
Softcover ISBN: 978-3-319-86639-0Published: 12 August 2018
eBook ISBN: 978-3-319-59504-7Published: 07 August 2017
Edition Number: 1
Number of Pages: XVI, 148
Number of Illustrations: 18 b/w illustrations, 35 illustrations in colour